61 results about "Deoxyribonuclease I" patented technology

The invention relates to a human amnion mesenchymal stem cell serum-free culture medium and a culture method thereof. The culture medium is formed by adding human serum albumin, human transferrin, human insulin and sodium selenite into a DMEM/F12 basic culture medium. The culture method for the culture medium comprises the following steps of: digesting human amnion by using trypsin, then digesting the human amnion by using collagenase IV and deoxyribonuclease I, and filtering the mixture to obtain single cell suspension; and adding the human serum albumin, the transferrin, the insulin and the sodium selenite into the DMEM/F12 basic culture medium in a ratio of VDMEM to VF12 of 1:1, and putting human amnion mesenchymal stem cells in a 37 DEG C CO2 incubator with saturated humidity and volume fraction of 5 percent under the serum-free condition, wherein culture in vitro and amplification are realized by solution change and transfer of culture, potentiality of multi-direction differentiation is maintained, and the amplified cells can be induced in vitro to form cartilage cells, osteoblasts and adipocytes. The culture medium and the culture method have the characteristics of no other animal sources, wide source and no limitation of ethics.

The present invention provides antibiofilm composition comprising two or more agents selected from the group consisting of DispersinB™, 5-Fluorouracil, Deoxyribonuclease I and Proteinase K for preventing growth and proliferation of biofilm-embedded microorganisms in wound care, oral care, and disease-related infections and methods of treatment in mammals. The invention further provides methods for preparing medical devices, and wound care devices using an antibiofilm composition comprising two or more antimicrobial agents selected from the group consisting of DispersinB™, 5-Fluorouracil, Deoxyribonuclease I and Proteinase K.

The invention discloses a staphylococcus aureus multiple PCR-MIX rapid detection kit and a detection method thereof; the detection kit comprises PCR MIX; wherein, the PCR MIX contains 2*PCR buffer, 1.0-3.0mmol/L of MgCl2, 180-220mu mol/L of dNTP each, heat-resisting deoxyribonuclease nuc gene primer of which the base sequence is SEQ NO.1 and the concentration of SEQ NO.1 is 100-600nmol/L, plasma-coagulase clfA gene primer of which the base sequence is SEQ NO.3 and the concentration of SEQ NO.4 is 100-600nmol/L, SmaI restriction fragment specific sequence primer of which the base sequence is SEQ NO.5 and the concentration of SEQ NO.6 is 100-600nmol/L, 20-60U of Taq enzyme and bromophenyl blue dye. The multiple PCR-MIX rapid detection kit and the detection method provided by the invention have simple configuration, the detection kit and the detection method can be used in industrialized production; the detection method is sensitive and has short detection cycle and strong maneuverability, so that the method can be widely applied in the fields of food hygiene, environmental monitoring, etc.

Methods and compositions for inhibiting and/or inactivating nucleases by employing nuclease inhibitors are provided. The nuclease inhibitors comprise anti-nuclease antibodies and non-antibody nuclease inhibitors. The anti-nuclease antibodies of the present invention may be a polyclonal or monoclonal antibodies, and may be anti-ribonuclease antibodies, anti-deoxyribonuclease antibodies, or antibodies to non-specific nucleases. A preferred embodiment comprises at least two nuclease inhibitors, and is referred to as a nuclease inhibitor cocktail. In some specific embodiments, the invention concerns methods of performing in vitro translation comprising obtaining a first nuclease inhibitor, which inhibitor is further defined as an anti-nuclease antibody, and placing the anti-nuclease antibody in an in vitro translation reaction. In many cases, the in vitro translation reaction comprises at least one nuclease, which may be a ribonuclease, a deoxyribonuclease, or a nonspecific nuclease. The invention also relates to kits for the performance of various microbiological procedures, which kits comprise the nuclease inhibitors described herein.

The invention relates to a construction method of a human amniotic mesenchymal stem cell bank. The construction method comprises the following steps: taking a human amnion for detection, flushing and washing the human amnion with a phosphate buffered solution, then smashing the human amnion, diluting with the phosphate buffered solution, digesting with trypsin, digesting with collagenase IV and deoxyribonuclease I, and filtering to obtain a single-cell suspension; by adding human serum albumin, transferring, insulin and sodium selenite into a DMEM/F12 basal culture medium with the ratio of VDMEM to VF12 being 1 to 1, placing human amnion mesenchymal stem cells in an incubator under the serum-free condition, and then performing liquid exchange and culture transfer; subjecting the mesenchymal stem cells obtained through in vitro culture and proliferation to liquid nitrogen refrigeration, and preserving the cells according to the gender of newborn infants, the ABO/Rh type and the HLA type; establishing cell information files, so that the human amniotic mesenchymal stem cell bank is constructed. The method has the characteristics of no other animal derivation, wide source range and no ethic limitation. With adoption of the method, the human amniotic mesenchymal stem cells can be provided for cell therapy and other application.

The disclosure provides articles and methods useful for detecting a discrete source of DNase activity. DNase-producing microorganisms can be detected. The device can further include selective agents and/or indicators to differentiate groups or species microorganisms. Methods of use include detecting or enumerating DNase- producing microorganisms.

The invention belongs to a cell DNA detection technology and in particular relates to a method for detecting 8-hydroxy-2'-deoxyguanosine (8-OHdG) and 2'-deoxyguanosin (dG) in cell DNA. The method can be used for quantitatively detecting the change of the content of 8-OHdG and dG in cell DNA, caused by exposure of harmful ingredients in cigarette smoke, so that the purpose of evaluating DNA oxidation damage caused by induction of the harmful ingredients can be achieved. According to the method, deoxyribonuclease I and alkaline phosphatase are used for hydrolyzing DNA in a cell, and deferoxamine mesylate is added into enzymatic hydrolysate, so that the oxidation of dG in the enzymolysis process is avoided; enzymatic hydrolysate is detected by HPLC-MS/MS; the cell DNA oxidation damage degree is evaluated according to the value of 8-OHdG/10<6>dG. By virtue of the method, the interference of high-concentration metal ions and artificial dG oxidation is removed, and thus the result is relatively accurate; the method is low in detection limit, high in sensitivity, good in repeatability and high in recovery rate.

The invention relates to a multi-enzyme system used for separating patient tumor tissue-originated primary cells. The system comprises components of, by weight: 0.02 to 0.2% of collagenase I-IV, 0.001 to 0.01% of hyaluronidase, 0.01 to 0.1% of trypsin, 0.02 to 0.2% of proteinase neutral, 0.001 to 0.01% of deoxyribonuclease I, and 5 to 50U/ml of elastase. The invention also relates to an application method of the system, an application of the system, and a kit formed by the system. The multi-enzyme system is advantaged in reasonable design. With the system, patient tumor tissue-originated primary cells can be separated with high specificity and high sensitivity. The separated primary cells are characterized by high survival rate, high purity, easy cryopreservation and easy resuscitation. The system and the kit can be used in medicine experimental evaluation, medicine toxicity testing, and medicine therapeutic performance determination. The system, the method and the kit are suitable to be widely popularized.

The invention relates to a method for preparing clinical-level adipose-derived stem cells. Specifically, the method includes the steps of firstly, washing adipose tissue with double-resistance salinecontaining mycillin mixed liquid, and cutting off and removing adipose; secondly, conducting chylosis on the adipose tissue obtained in the first step; thirdly, adding the adipose tissue subjected tochylosis in the second step to an a-MEM containing an enzyme mixture to be digested, wherein the enzyme mixture contains I-type collagenase, hyaluronidase, deoxyribonuclease I and trypsin; fourthly, centrifuging digested liquid in the third step, and removing supernate to obtain the adipose-derived stem cells.

The invention discloses a detection method for staphylococcus aureus. The detection method comprises the following steps: preparing a double-fluorescence-label probe with two carboxy flouorescein labels from a first probe, a second probe and a single-chain DNA; mixing the double-fluorescence-label probe with a graphene oxide solution, thus forming a compound solution; extracting the total RNA of a bacteria solution to be detected; simultaneously adding the total RNA and deoxyribonuclease into the compound solution, thus forming a mixed solution, and incubating the mixed solution; measuring a fluorescence value of the incubated mixed solution, and calculating the concentration of the staphylococcus aureus according to the fluorescence value. According to the detection method disclosed by the embodiment of the invention, a section of specifically recognized staphylococcus aureus 16S rRNA is used as a target to design the probe, and a double-fluorescent-label probe/graphene oxide system is built based on the fluorescence superposition principle; cyclic detection on the target is realized according to the characteristic of the deoxyribonuclease, so that a fluorescence signal is amplified, the sensitivity of the detection method for the staphylococcus aureus is improved, and the detection efficiency of the detection method is also improved.

The invention discloses a rapid construction method of a genome DNA sequencing library, and a matched kit. The method comprises the following steps: (1) selecting DNase I deoxyribonuclease I as a DNAfragmenting enzyme to fragment a sample DNA by enzyme digestion to obtain fragmented DNA; (2) directly adding a dA tail to the fragmented DNA to obtain DNA with the dA tail; (3) connecting the DNA with the dA tail with a joint to obtain a joint connected product; (4) carrying out magnetic-bead purification on the joint connected product; (5) carrying out polymerase chain reaction (PCR) amplification on the joint connected product to obtain an amplification product; (6) carrying out magnetic-bead purification on the amplification product to obtain a genome DNA sequencing library product; and (7) carrying out fragment distribution inspection and library evaluation on the library product by adopting an agarose gel electrophoresis detection method. According to the invention, the DNase I is selected as the DNA fragmenting enzyme, so that the steps of tail end repair and phosphorylation are reduced, the library construction time is shorter, and cost is lower.

In order to simply obtain a methylated DNA sample, a method including bringing a sample which may include methylated DNA into contact with a protein capable of binding to methylated DNA to bind the methylated DNA in the sample to the protein, bringing the sample obtained into contact with at least one deoxyribonuclease to degrade DNA in the sample; and detecting methylated DNA which is not degraded by the deoxyribonuclease by the binding of the sample obtained to the protein is used. In the method, at least one type of deoxyribonucleases is a deoxyribonuclease different from a methylation-sensitive restriction enzyme capable of degradating a single stranded DNA.

The invention relates to the field of single cell separation, and discloses a method for separating single cells from a sample. The method comprises the steps that the normal tissue sample is mixed with digestive juice for digestion, wherein the digestive juice contains VIII-type collagenase, neutral protease, a trypsin inhibitor and deoxyribonuclease; the ratio between enzyme activity units of the VIII-type collagenase, the neutral protease, the trypsin inhibitor and the deoxyribonuclease is (100-312.5):(1-5):(5000-25000):1. The method can achieve high-yield and high-activity extraction of the single cells under the condition that the total digestion time is short, especially pancreatic tissue, and the problem that existing pancreatic tissue single cells are relatively low in yield and activity is solved.

The invention discloses a colorimetric detection method for deoxyribonuclease I (DNase I) activity based on DNA regulating MIL-53(Fe) peroxidase activity. The invention uses cheap 3, 3 ', 5, 5'-Tetramethylbenzidine (TMB) is a colorimetric substrate, which can regulate MIL-53 (Fe) peroxidase activity and the hydrolysis of ssDNA by DNase I, a biosensor is constructed to observe the activity of DNaseI with naked eyes. A colorimetric method with the advantages of low cost, simple operation and convenience has been developed. This method has high sensitivity and good stability, and is suitable forpopularization and application.

The invention discloses a scylla paramamosain double-stranded specific deoxyribonuclease as well as a preparation method and an application thereof and relates to double-stranded specific deoxyribonucleases. The preparation method comprises the steps of extracting total RNA (Ribose Nucleic Acid) of hepatopancreas of scylla paramamosain, carrying out reverse transcription on the total RNA by using an RT-PCR (Reverse Transcription-Polymerase Chain Reaction) technology to obtain cDNA (complementary Deoxyribose Nucleic Acid), obtaining a new DSN (Duplex-Specific Nuclease) gene by utilizing a SMART II-RACE method, constructing a prokaryotic expression recombinant plasmid of the scylla paramamosain by utilizing a genetic recombination method and carrying out high-efficiency expression and purification in escherichia coli to obtain recombinant scylla paramamosain DSN with biological activity. The invention provides a recombinant vector, comprising the gene sequence of the scylla paramamosain double-stranded specific deoxyribonuclease. The invention provides a biological agent which contains the scylla paramamosain double-stranded specific deoxyribonuclease and is applied to degrading double-stranded DNA.

The invention discloses a preparation method of pathogenic bacterium DNAs (Deoxyribonucleic Acids) in a clinical blood sample and a kit. The method comprises the following steps of: mixing the clinical blood sample with ox-bile or ox-bile powder and making the ox-bile or ox-bile powder crack non-pathogenic bacterium cells; during or after cracking of the non-pathogenic bacterium cells, adding desoxyribonuclease for degrading DNAs released after cracking of the non-pathogenic bacterium cells; centrifuging the mixture obtained in the previous step and collecting precipitates; and preparing pathogenic bacterium DNAs from the precipitates with the conventional method. In the invention, the ox-bile or ox-bile powder is used for cracking the non-pathogenic bacterium cells in the clinical blood sample to release the non-pathogenic bacterium cell DNAs according to the characteristic of the tolerance of malignant bacteria and fungi in the clinical sample to the ox-bile and the ox-bile powder, and desoxyribonuclease is used for degrading to selectively remove non-pathogenic bacterium DNAs, so that the pathogenic bacterium DNAs are enriched. By undergoing a PCR (Polymerase Chain Reaction) on the DNAs, the interference of most of non-pathogenic bacterium DNAs on the PCR detection of pathogenic bacteria can be avoided, and the specificity and sensitivity of the PCR can be enhanced.

The present invention discloses a small molecular double stranded RNA group prepared from yeast, a preparation method and a use thereof. According to the present invention, the small molecular double stranded RNA group is prepared through adopting a mixture and the total RNA of the yeast as substrates, wherein the mixture comprises at least two selected from ribonuclease T1, deoxyribonuclease I and ribonuclease III, the yeast is the yeast which kills plasmids. The small molecular double stranded RNA group provided by the present invention can be provided for preparing cancer prevention care products, anti-cancer health care products and anti-virus health care products. The preparation method provided by the present invention is simple, and is easy to operate.

The invention discloses a plaque tissue digestion kit. The plaque tissue digestion kit comprises L enzyme: Liberase Tm, E enzyme: elastinase, D enzyme: deoxyribonuclease I, and HBSS, wherein the HBSScontains BSA and EDTA. The invention further discloses application of the plaque tissue digestion kit in a plaque tissue. The kit is mainly invented for digesting the plaque tissue; the enzymes are combined, so that the plaque tissue can be quickly digested into single-cell suspension; biological reaction of the plaque tissue is researched on the basis of single cells, so that a condition that a flow cytometry upper machine or follow-up data analysis results are affected by a lot of calcified cell debris, large calcified tissues and the like is avoided.